Welcome to our dedicated page for iSpecimen news (Ticker: ISPC), a resource for investors and traders seeking the latest updates and insights on iSpecimen stock.
iSpecimen Inc., headquartered in Lexington, MA, is a leading marketplace for human biospecimens. The company provides researchers with the specimens they need from the patients they want through its innovative iSpecimen Marketplace. This online platform connects healthcare organizations with access to patients and specimens with scientists in need of these vital resources.
Utilizing proprietary, cloud-based technology, iSpecimen enables researchers to intuitively search for specimens across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. This system allows for easy and compliant access to specimens, facilitating scientific discovery and advancing healthcare for all.
iSpecimen stands out by offering a unique value proposition to both researchers and partner sites. Researchers gain the necessary resources to drive their studies, while partner sites can contribute to biomedical discovery and benefit financially. The company caters to a global market, with operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority of its revenue coming from the Americas.
In recent news, iSpecimen has achieved a sequential quarterly revenue growth of 75%, driven by enhanced operational efficiencies and new business initiatives. The company continues to expand its network by adding new suppliers and reinforcing existing relationships to provide researchers with increased access to highly sought-after biospecimens, especially for oncology research. Additionally, iSpecimen is making strides in quality control and assurance through digital AI histopathology services, enhancing data quality and operational efficiency.
For investors and media inquiries, iSpecimen's contacts at KCSA Strategic Communications are available for further information.
iSpecimen (Nasdaq: ISPC), a market leader in providing biospecimens for medical research, announced CEO Tracy Curley's participation at the Aegis Conference from May 2-4, 2023. Curley is scheduled to present on May 4 at 4:30 p.m. ET. The conference will be held virtually, catering to a global audience interested in biospecimen solutions for scientific research.
iSpecimen connects researchers with healthcare specimen providers through its innovative online marketplace, which enables easy access to human biospecimens necessary for medical discovery. The company utilizes proprietary technology that allows users to search for specimens across a vast network of partner healthcare organizations. This strategic engagement at the Aegis Conference highlights iSpecimen's commitment to advancing medical research through improved specimen accessibility.
iSpecimen (Nasdaq: ISPC) announced its financial results for the first quarter ending March 31, 2023, will be reported on May 4, 2023, before market opens. A conference call will be held at 8:30 a.m. ET that day, featuring comments from CEO Tracy Curley. Investors can join the live call by dialing +1-844-826-3033 (U.S. Toll Free) or +1-412-317-5185 (International). The conference call will also be available via audio webcast on iSpecimen's website. A replay of the call will be accessible until May 18, 2023. iSpecimen is a global online marketplace that connects researchers with healthcare specimen providers, aimed at advancing medical research through biospecimen procurement.
FAQ
What is the current stock price of iSpecimen (ISPC)?
What is the market cap of iSpecimen (ISPC)?
What is iSpecimen Inc.?
Where is iSpecimen Inc. headquartered?
How does the iSpecimen Marketplace work?
What kind of specimens does iSpecimen provide?
What recent achievements has iSpecimen made?
Who can benefit from using iSpecimen's services?
What regions does iSpecimen operate in?
How can researchers access iSpecimen's services?
How does iSpecimen ensure quality control?
How can investors get in touch with iSpecimen?
